✦ LIBER ✦

Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial

✍ Scribed by Samuel Z. Goldhaber; Craig M. Kessler; John A. Heit; C.Gregory Elliott; William R. Friedenberg; Darell E. Heiselman; David B. Wilson; John Anthony Parker; Don Bennett; Michael L. Feldstein; Andrew P. Selwyn; Ducksoo Kim; G.V.R.K. Sharma; James S. Nagel; Michael F. Meyerovitz

Book ID: 119169440
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 625 KB
Volume: 20
Category: Article
ISSN: 1558-3597
DOI: 10.1016/0735-1097(92)90132-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter, randomized, placebo-contr

A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction

✍ Eric J. Topol; Douglas C. Morris; Richard W. Smalling; Richard R. Schumacher; Ch 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 801 KB

A randomized placebo-controlled trial of

A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction

✍ Elizabeth G. Nabel; Eric J. Topol; Anita Galeana; Stephen G. Ellis; Eric R. Bate 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 837 KB

Randomized controlled trial of late in-h

Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction

✍ Gabriel I. Barbash; Arie Roth; Hanoch Hod; Michaela Modan; Hilton I. Miller; She 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 863 KB

A randomized trial confirming the effica

A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: The TUCC trial

✍ Allan M. Ross; Runlin Gao; Karin S. Coyne; Jilin Chen; Kangbao Yao; Yuejin Yang; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 79 KB

A Randomized, Blinded Study of Two Doses

A Randomized, Blinded Study of Two Doses of Novastan® (Brand of Argatroban) Versus Heparin as Adjunctive Therapy to Recombinant Tissue Plasminogen Activator (Accelerated Administration) in Acute Myocardial Infarction: Rationale and Design of the Myocardial Infarction using Novastan® and T-PA (MINT) Study

✍ Ik-Kyung Jang; Robert P. Giugliano; Thomas J. Massey; Richard P. Schwarz 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 133 KB